Karaca, Irmak http://orcid.org/0000-0001-7927-0887
Uludag, Gunay
Matsumiya, Wataru
Regenold, Jonathan
Or, Christopher
Mobasserian, Azadeh
Halim, Muhammad Sohail
Zaidi, Moosa http://orcid.org/0000-0003-1788-6306
Lajevardi, Sherin
Dongchau, Ami
Ghoraba, Hashem http://orcid.org/0000-0002-1145-4134
Nguyen, Quan Dong http://orcid.org/0000-0002-6024-8441
Article History
Received: 2 March 2022
Revised: 3 September 2022
Accepted: 11 November 2022
First Online: 28 November 2022
Competing interests
: QDN serves on the Scientific Advisory Board for Affibody, Acelyrin, and Regeneron. The remaining authors declare that there are no conflicts of interest related to this manuscript.